REQUEST A DEMO
Total
USD $0.00
Search more companies

Xelios - Pharm OOD (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Xelios - Pharm OOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Xelios - Pharm OOD is a company in Bulgaria, with a head office in Dupnitsa. The enterprise operates in the Pharmacies and Drug Stores industry. Xelios - Pharm OOD was incorporated on 2015. It currently has a total number of 22 (2023) employees. From the latest financial highlights, Xelios - Pharm OOD reported a net sales revenue increase of 42.24% in 2021. Its total assets decreased by 0.07% over the same period. Xelios - Pharm OOD’s net profit margin increased by 0.13% in 2021.

Headquarters
Hristo Botev 18
Dupnitsa; Kyustendil; Postal Code: 2600

Contact Details: Purchase the Xelios - Pharm OOD report to view the information.

Basic Information
Total Employees:
Purchase the Xelios - Pharm OOD report to view the information.
Outstanding Shares:
Purchase the Xelios - Pharm OOD report to view the information.
Registered Capital:
Purchase the Xelios - Pharm OOD report to view the information.
Incorporation Date:
2015
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
36%
Purchase this report to view the information.
34%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Xelios - Pharm OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
42.24%
Total operating revenue
41.9%
Operating profit (EBIT)
44.05%
EBITDA
39.68%
Net Profit (Loss) for the Period
50.35%
Total assets
-0.07%
Total equity
38.48%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
0.13%
Return on Equity (ROE)
2.2%
Quick Ratio
-0.45%
Cash Ratio
-0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?